
2020 FDA Final Guidance, “In Vitro Drug Interaction Studies– Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions”
We are proud to have been cited in this final guidance for industry document, which was released by the FDA in January 2020. Access full PDF here:
Popular Access ADMETM resources related to this document:
Webinar: Analysis of Updates in this Document & Comparison to the Current EMA & PMDA Guidance | Scientific Poster: Updated DDI Guidance Comparison | Request a Gap Analysis